This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

John Maraganore, PhD
Chief Executive Officer at Alnylam Pharmaceuticals, Inc


John Maraganore, Ph.D., has been the CEO of Alnylam Pharmaceuticals since 2002. Prior to Alnylam, he held positions at Millennium Pharmaceuticals, Biogen (where he co-invented bivalirudin), Zymogenetics, and The Upjohn Company. He received his Ph.D. In biochemistry and molecular biology from the University of Chicago. Dr. Maraganore is the immediate past chair of the Biotechnology Innovation Organization (BIO) and a member of the BIO Executive Committee and is a Director of Agios Pharmaceuticals.

Agenda Sessions

  • Keynote Introduction by Session Chair and KEYNOTE PRESENTATION with Live Q&A - Bringing RNAi Therapeutics to Patients Around the World